Fulcrum Therapeutics FULC
NASDAQ FULC
$3.85 +0.01 (+0.26%)
As of: Sep 4, 2026 · 3:59 PM EDT

Fulcrum Therapeutics (FULC) Invested Capital (2018 - 2022)

Analysis

Fulcrum Therapeutics (FULC) Invested Capital (2018 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 33.70 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 7.35 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 6.25 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - 19.13 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.30 Bn
10 Fulcrum Therapeutics 293.24 Mn 293.24 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 198.94 Mn
Sep 30, 2022 221.41 Mn
Jun 30, 2022 160.76 Mn
Mar 31, 2022 189.16 Mn
Dec 31, 2021 214.12 Mn
Sep 30, 2021 233.31 Mn
Jun 30, 2021 113.71 Mn
Mar 31, 2021 130.69 Mn
Dec 31, 2020 98.23 Mn
Sep 30, 2020 108.15 Mn
Jun 30, 2020 125.42 Mn
Mar 31, 2020 74.04 Mn
Dec 31, 2019 90.67 Mn
Sep 30, 2019 105.77 Mn
Jun 30, 2019 -107.93 Mn
Dec 31, 2018 -59.68 Mn